藍十字與大灣區醫療機構策略合作 客戶可在大灣區進行跨境手術及諮詢服務
友邦保險(01299.HK)旗下藍十字今日(4日)宣布,與和睦家、香港綜合腫瘤中心和希愈腫瘤中心,及中山陳星海醫院合作,構建大灣區醫療保健生態圈,為香港客戶提供跨境點對點無縫銜接的醫療旅程。
透過是次合作,藍十字的合資格個人及團體醫療保險客戶可直接預約前往和睦家位於大灣區的兩家綜合性醫院,深圳新風和睦家醫院及廣州和睦家醫院、以及中山陳星海醫院進行跨境手術及諮詢服務。醫療諮詢後,若需進行手術或醫療程序,院方醫生會為客戶申請預先評估,以安排醫療費用直付服務。
此外,癌症客戶亦可預約新風天域集團旗下的香港綜合腫瘤中心及希愈腫瘤中心,獲得影像診斷及腫瘤治療服務。如有需要,亦可透過其大灣區癌症治療網絡,選擇合適的跨境醫療服務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.